Evaluation and management of acute pancreatitis in Spain
- Resource Type
- Authors
- Francisco Valverde-López; C. Mel Wilcox; Eduardo Redondo-Cerezo
- Source
- Gastroenterología y Hepatología (English Edition). 41:618-628
- Subject
- Adult
Male
medicine.medical_specialty
Web of science
Severity of Illness Index
03 medical and health sciences
Enteral Nutrition
0302 clinical medicine
Risk Factors
Intensive care
Epidemiology
medicine
Humans
Biliary pancreatitis
Prospective Studies
Intensive care medicine
Aged
Retrospective Studies
Cholangiopancreatography, Endoscopic Retrograde
Hepatology
business.industry
Incidence
Incidence (epidemiology)
Gastroenterology
Disease Management
Middle Aged
medicine.disease
Combined Modality Therapy
Anti-Bacterial Agents
Bowel sounds
Pancreatitis
Spain
030220 oncology & carcinogenesis
Etiology
Fluid Therapy
Acute pancreatitis
Female
030211 gastroenterology & hepatology
business
Biomarkers
- Language
- ISSN
- 2444-3824
Introduction The aim of this systematic review is to summarize epidemiological data and areas of future acute pancreatitis research in Spain. Methods We conduct an independent search in PubMed and Web of Science and analyse articles by Spanish researchers from 2008 to 2018. Results We identified an overall incidence of 72/100,000 person-years, with biliary pancreatitis as the most common etiology. BISAP was useful but suboptimal for predicting severity and some biomarkers such as Oleic acid chlorohydrin have shown promising results. The modified determinant-based classification can help to classify patients admitted to intensive care units. Ringer's lactate solution is currently the fluid of choice and classic surgery has been surpassed by minimally-invasive approaches. Starting a full-caloric diet is safe when bowel sounds are present. Discussion There are numerous well-defined research fields in Spain. Future multicentre studies should focus on management, predicting severity and cost-effectiveness.